Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Opus Genetics (IRD) Enterprise Value (2021 - 2024)

Opus Genetics (IRD) has disclosed Enterprise Value for 8 consecutive years, with -$42.4 million as the latest value for Q3 2023.

  • On a quarterly basis, Enterprise Value fell 203.53% to -$42.4 million in Q3 2023 year-over-year; TTM through Sep 2023 was -$42.4 million, a 203.53% decrease, with the full-year FY2022 number at -$42.7 million, down 72.44% from a year prior.
  • Enterprise Value was -$42.4 million for Q3 2023 at Opus Genetics, down from -$40.0 million in the prior quarter.
  • In the past five years, Enterprise Value ranged from a high of -$10.6 million in Q1 2021 to a low of -$42.7 million in Q4 2022.
  • A 3-year average of -$27.0 million and a median of -$24.2 million in 2021 define the central range for Enterprise Value.
  • Peak YoY movement for Enterprise Value: surged 38.34% in 2022, then plummeted 203.53% in 2023.
  • Opus Genetics' Enterprise Value stood at -$24.8 million in 2021, then tumbled by 72.44% to -$42.7 million in 2022, then increased by 0.75% to -$42.4 million in 2023.
  • Per Business Quant, the three most recent readings for IRD's Enterprise Value are -$42.4 million (Q3 2023), -$40.0 million (Q2 2023), and -$39.0 million (Q1 2023).